Comparative effects of carrier proteins on vaccine-induced immune response
Authors:
- Markus KnufMKMarkus Knuf
- Frank KowalzikFKFrank Kowalzik
- Dorothee KieningerDKDorothee Kieninger
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young childrenVaccine, 2010
- Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all agesVaccine, 2009
- Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in AdolescentsClinical Infectious Diseases, 2009
- The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infantsVaccine, 2009
- Protein D of Haemophilus influenzae: A Protective Nontypeable H. influenzae Antigen and a Carrier for Pneumococcal Conjugate VaccinesClinical Infectious Diseases, 2008
- Prospects for Vaccine Prevention of Meningococcal InfectionClinical Microbiology Reviews, 2006
- Haemophilus influenzae type b conjugate vaccinesImmunology, 2004
- A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes.Proceedings of the National Academy of Sciences, 1992
- Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccinesThe Journal of Pediatrics, 1992
- Reconstitution of Diphtheria Toxin from Two Nontoxic Cross-Reacting Mutant ProteinsScience, 1972